• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs.

作者信息

Leroux J C, Cozens R M, Roesel J L, Galli B, Doelker E, Gurny R

机构信息

School of Pharmacy, University of Geneva, Switzerland.

出版信息

Pharm Res. 1996 Mar;13(3):485-7. doi: 10.1023/a:1016073416332.

DOI:10.1023/a:1016073416332
PMID:8692747
Abstract
摘要

相似文献

1
pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs.pH敏感纳米颗粒：改善犬类体内HIV-1蛋白酶抑制剂口服递送的有效手段。
Pharm Res. 1996 Mar;13(3):485-7. doi: 10.1023/a:1016073416332.
2
Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state.掺入pH敏感颗粒中的难溶性HIV-1蛋白酶抑制剂的口服生物利用度：粒径和营养状态的影响。
J Control Release. 2000 Aug 10;68(2):291-8. doi: 10.1016/s0168-3659(00)00272-8.
3
Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice.一种新型HIV-1蛋白酶抑制剂在静脉注射和口服给予小鼠后，掺入可生物降解或肠溶纳米颗粒中的药代动力学。
J Pharm Sci. 1995 Dec;84(12):1387-91. doi: 10.1002/jps.2600841202.
4
Parallel monitoring of plasma and intraluminal drug concentrations in man after oral administration of fosamprenavir in the fasted and fed state.在空腹和进食状态下口服福沙普那韦后，对人体血浆和管腔内药物浓度进行平行监测。
Pharm Res. 2007 Oct;24(10):1862-9. doi: 10.1007/s11095-007-9307-3. Epub 2007 Apr 19.
5
Colorectal delivery and retention of PEG-Amprenavir-Bac7 nanoconjugates--proof of concept for HIV mucosal pre-exposure prophylaxis.聚乙二醇-安普那韦-杆菌肽7纳米缀合物在结肠的递送与保留——HIV黏膜暴露前预防的概念验证
Drug Deliv Transl Res. 2016 Feb;6(1):1-16. doi: 10.1007/s13346-015-0269-4.
6
Warning for oral solution.口服溶液剂警示。
AIDS Patient Care STDS. 2000 Sep;14(9):519-20.
7
Single-dose safety and pharmacokinetics of brecanavir, a novel human immunodeficiency virus protease inhibitor.新型人类免疫缺陷病毒蛋白酶抑制剂布雷卡韦单剂量安全性及药代动力学
Antimicrob Agents Chemother. 2006 Jun;50(6):2201-6. doi: 10.1128/AAC.01490-05.
8
Optimized self-nanoemulsifying drug delivery system of atazanavir with enhanced oral bioavailability: in vitro/in vivo characterization.优化的阿扎那韦自微乳给药系统，提高口服生物利用度：体外/体内特征研究。
Expert Opin Drug Deliv. 2014 Jul;11(7):1023-32. doi: 10.1517/17425247.2014.913566. Epub 2014 May 12.
9
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Atazanavir--booster of the future?第四届HIV治疗临床药理学国际研讨会报告。阿扎那韦——未来的增效剂？
TreatmentUpdate. 2003 Apr-May;15(3):5-6.
10
Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients.
AIDS. 2003 Dec 5;17(18):2669-71. doi: 10.1097/00002030-200312050-00017.

引用本文的文献

1
Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.纳米技术对抗 COVID-19：免疫、诊断和治疗研究。
J Control Release. 2021 Aug 10;336:354-374. doi: 10.1016/j.jconrel.2021.06.036. Epub 2021 Jun 25.
2
"Fusion and binding inhibition" key target for HIV-1 treatment and pre-exposure prophylaxis: targets, drug delivery and nanotechnology approaches.“融合与结合抑制”：HIV-1治疗和暴露前预防的关键靶点——靶点、药物递送与纳米技术方法
Drug Deliv. 2017 Nov;24(1):608-621. doi: 10.1080/10717544.2016.1228717.
3
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives.
蛋白质和肽类口服给药策略及其临床前景综述。
Saudi Pharm J. 2016 Jul;24(4):413-28. doi: 10.1016/j.jsps.2014.06.004. Epub 2014 Jun 16.
4
Fabrication, modeling and characterization of multi-crosslinked methacrylate copolymeric nanoparticles for oral drug delivery.用于口服给药的多交联甲基丙烯酸酯共聚物纳米颗粒的制备、建模与表征
Int J Mol Sci. 2011;12(9):6194-225. doi: 10.3390/ijms12096194. Epub 2011 Sep 23.
5
Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves.介孔硅纳米粒子中 pH 敏感型纳米阀的自主式体外抗癌药物释放。
J Am Chem Soc. 2010 Sep 15;132(36):12690-7. doi: 10.1021/ja104501a.
6
Polymeric particulates to improve oral bioavailability of peptide drugs.用于提高肽类药物口服生物利用度的聚合物微粒
Molecules. 2005 Jan 31;10(1):65-80. doi: 10.3390/10010065.
7
pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs.pH依赖性溶解的纳米和微粒用于改善犬类中高亲脂性化合物的口服给药。
AAPS PharmSci. 2001;3(1):E8. doi: 10.1208/ps030108.
8
The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent.可生物降解微粒在Caco-2细胞中的摄取机制取决于颗粒大小。
Pharm Res. 1997 Nov;14(11):1568-73. doi: 10.1023/a:1012126301290.